811 material Form 8-K filings that 685 companies we cover made with the SEC in April 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
SLB Executive Vice President of Geographies Khaled Al Mogharbel will step down effective May 1, 2025, after a 30-year career with the company. He will serve as an adviser to the chief executive through May 1, 2028, to help transition the Geographies organization, and the filing describes restrictive covenants and a three-year payment package tied to that role.
Al Mogharbel indicated his departure on April 7, 2025; it takes effect May 1, 2025.
Under the advisory agreement, he will receive an annual cash payment equal to 75% of his current base salary for three years.
He will receive a 2025 cash incentive prorated to May 1, 2025, paid at target, and his outstanding equity awards will continue to vest.
The full agreement will be filed as an exhibit to SLB's Form 10-Q for the quarter ending June 30, 2025.
CVS Health appointed Brian O. Newman, former CFO of United Parcel Service, as executive vice president and chief financial officer effective May 12, 2025, replacing Thomas F. Cowhey, who becomes a strategic advisor to the CEO. The company also named Amy L. Compton-Phillips, M.D. as chief medical officer effective May 19, 2025. The filing also says the company currently expects 2025 results to meet or exceed prior guidance, based on year-to-date results through February, while first-quarter closing procedures are not yet complete.
Brian O. Newman becomes CFO effective May 12, 2025, and is CFO designate from April 21, 2025; he will receive a $1.0 million annualized base salary and a $7.0 million target annual equity award
Thomas F. Cowhey ceases to be CFO on May 12, 2025, and will remain as Strategic Advisor to the President and CEO until a departure date not yet determined
Amy L. Compton-Phillips, M.D. becomes executive vice president and chief medical officer effective May 19, 2025
Company expects 2025 financial results will meet or exceed previously issued guidance, but first-quarter 2025 financial closing is not yet complete and results may change
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.